Nanobiotix (NBTX) Enterprise Value (2018 - 2025)
Nanobiotix (NBTX) posted Enterprise Value of -$61.5 million for Q4 2025, down 15.64% on a QoQ basis from -$53.1 million in Q4 2024, and down 15.64% year-over-year from -$72.9 million in Q4 2024.
Nanobiotix (NBTX) has 8 years of Enterprise Value data on file, last reported at -$61.5 million in Q4 2025.
- In Q4 2025, Enterprise Value fell 15.64% year-over-year to -$61.5 million; the TTM figure through Dec 2025 stood at -$61.5 million (down 15.64% YoY), while the FY2025 annual figure was -$59.7 million, down 10.81% from the prior year.
- Enterprise Value eased to -$61.5 million in Q4 2025, from -$53.1 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$42.2 million in Q4 2022 and bottomed at -$96.0 million in Q4 2021.
- A 5-year average of -$66.8 million and a median of -$61.5 million in 2025 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value surged 56.02% — and 2023, when it slumped 91.82%.
- Year by year, Enterprise Value stood at -$96.0 million in 2021, then surged by 56.02% to -$42.2 million in 2022, then slumped by 91.82% to -$81.0 million in 2023, then soared by 34.38% to -$53.1 million in 2024, then retreated by 15.64% to -$61.5 million in 2025.
- The last three Enterprise Value figures came in at -$61.5 million (Q4 2025), -$53.1 million (Q4 2024), and -$81.0 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -1.91 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -61.40 Mn |
| Jun 30, 2025 | -56.30 Mn |
| Dec 31, 2024 | -53.15 Mn |
| Jun 30, 2024 | -81.07 Mn |
| Dec 31, 2023 | -81.00 Mn |
| Jun 30, 2023 | -45.07 Mn |
| Dec 31, 2022 | -42.23 Mn |
| Jun 30, 2022 | -89.55 Mn |
| Dec 31, 2021 | -96.00 Mn |
| Jun 30, 2021 | -143.49 Mn |
| Dec 31, 2020 | -142.06 Mn |
| Dec 31, 2019 | -38.85 Mn |
| Dec 31, 2018 | -41.32 Mn |